Brand profile · Nanotechnology Research

SA Nano

Adelaide, South Australia-based SA Nano operates in Nanotechnology Research. Privately held, at sanano.com.au. It holds one address on record, all in Australia. It employs 1 person, on the record. It lists nanoparticle synthesis and microfluidics among its specialties. One Australian registration (ABN) is a confirmed match. It is listed alongside six similar brands, mostly in Business Consulting.

LinkedIn

Profile live Privately Held Founded 2025 1 entity ABN 1 office country
Registry verified · ABR
Counted staff
1
self-reported band not used
Founded
2025
1 years
Legal entities
1
ABR
Office countries
1
1 address
Funding rounds
None on record
Company type
Privately Held
self-reported
Use this profile Compare Your shortlist

Legal entity

1 brand → 1 confirmed entity

  • SA NANO PTY LTD

    ABN50685489712

    SAHigh confidenceMatched on exact nameABR

Legal entities

SA Nano: 1 registry entitySA Nano is linked to 1 registry entity: SA NANO PTY LTD (ABN 50685489712, candidate).SA NanoSA NANO PTY LTDABN 50685489712Candidate · High confidence
Show as table
SA NANO PTY LTDABN 50685489712
Confirmed matches0 of 1

A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.

Description

SA Nano is an Adelaide-based microfluidics company dedicated to advancing nanomedicine research through cutting edge, user-focused technology. Founded in 2025 and supported by the University of Adelaide, our team is led by experienced and passionate researchers in this field.

Nanomedicines are revolutionizing healthcare, from Covid-19 vaccines to treatment for cancers and genetic diseases. Yet producing high-quality nanomedicines is challenging, requiring significant expertise and costly equipment.

We've experienced these challenges firsthand. That's why SA Nano is committed to making nanomedicine production accessible to all researchers. Our intuitive platforms, designed for speed, precision, affordability, and reproducibility, empower scientists to accelerate the development of life-changing therapies. With our nanoGo series, anyone can produce lipid and polymeric nanoparticles anywhere, anytime, with zero prior experience required.

Specialties

All 1 specialty
  • nanoparticle synthesis and microfluidics

Locations

Australiaprimary

Country footprint

Offices in 1 countryCountry footprint: 1 country, primary AU. Codes: AU.1 countryprimary AUAU
Show as table
Countries1
Primary countryAU

All codes: AU

Addresses

  • AUAdelaide, South AustraliaPrimary

Grid intelligence Members

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Notify me about spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend
Notify me about signals

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
Notify me about financials

People & contacts

1 employee profiles on record · names withheld.

The people relation is never requested, so there is nothing here to unlock.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

Which legal entity operates under SA Nano?

One South Australia entity on the ABR: SA NANO PTY LTD (ABN 50 685 489 712), high confidence.

How many people work at SA Nano?

1 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.

Where does SA Nano have offices?

One address on record, Australia only. Primary: Adelaide, South Australia.

Has SA Nano raised funding?

None linked to this brand.

What does SA Nano list as its specialties?

One tag on the brand's own list, among them nanoparticle synthesis and microfluidics.

Which companies are listed alongside SA Nano?

Six peer profiles on record: Bridgewater Advisory and Affinyx.